Portrait_default
ciachef
Sex: M
Data Quality: 2 stars
MS: 10 yrs
Type: Relapsing-Remitting
Sensation: Moderate
Overall: Moderate
Cognition: moderate
Vision: moderate
Speech: moderate
Swallowing: moderate
Upper limb: moderate
Walking: moderate
ciachef
Male, 32 years
Glen Burnie, MD
Primary Condition
MS
Type
Relapsing-Remitting
First symptom
Diagnosis
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

ciachef's Natalizumab is for:

  • MS

ciachef has not reported any side effects for Natalizumab.

ciachef's Natalizumab History (Stopped)
300 mg/15 mL Monthly Nov 02, 2009 - Jan 10, 2012
Stopped Doctor's advice Jan 10, 2012
Evaluations
Date Dosage MS (Multiple Sclerosis) Perceived effectiveness Side Effects Adherence Burden
Mar 22, 2012   Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4 NoneNoneNoneNone AlwaysAlwaysAlwaysAlways SomewhatSomewhatSomewhatSomewhat
Date
Mar 22, 2012
Advice & Tips
I really hated coming off of this drug. Some of my MRI's actually showed repair to my system. In the end the risk of PML got to be too great and I had to stop, but man, what a great treatment.
Cost
< $25 monthly

About Natalizumab (Prescription Drug)

Natalizumab is a monoclonal antibody given by infusion and used in the treatment of MS and Crohn's disease. It has been shown to slow progression and reduce relapses in MS. It is currently sold under the brand name Tysabri.

Learn more about Natalizumab in our Natalizumab Community Report.

Back to ciachef's Profile